UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Evaluation of Therapeutic Tissue Crosslinking (TXL) for Myopia Using Second Harmonic Generation Signal Microscopy in Rabbit Sclera

Investigative ophthalmology & visual science, 2017-01, Vol.58 (1), p.21-29

2017

Volltextzugriff (PDF)

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Journal of visualized experiments, 2018-01 (131)

2018

Volltextzugriff (PDF)

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Journal of visualized experiments, 2018-01 (131)

2018

Volltextzugriff (PDF)

Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4535-4535

2015

Volltextzugriff (PDF)

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11509-e11509

2011

Volltextzugriff (PDF)

Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7519-7519

2011

Volltextzugriff (PDF)

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8016-8016

2009

Volltextzugriff (PDF)

Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4539-4539

2008

Volltextzugriff (PDF)

Follow up of a multicenter phase II study of sequential paclitaxel and S-1 (TXL/S1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15084-15084

2007

Volltextzugriff (PDF)

A multicenter phase II study of sequential paclitaxel and S-1 (TXL/S-1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4067-4067

2005

Volltextzugriff (PDF)

Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5084-5084

2005

Volltextzugriff (PDF)

A bumblebee thioredoxin-like protein gene that is up-regulated by a temperature stimulus and lipopolysaccharide injection

European journal of entomology, 2006-04, Vol.103 (2), p.291-296

2006

Volltextzugriff (PDF)

Tongxinluo promotes mesenchymal stem cell tube formation in vitro

Journal of Zhejiang University. B. Science, 2011-08, Vol.12 (8), p.644-651

2011

Volltextzugriff (PDF)

Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

Clinical cancer research, 2012-08, Vol.18 (15), p.4114-4121

2012

Volltextzugriff (PDF)

Vacuolar H+‐ATPase inhibitors overcome Bcl‐xL‐mediated chemoresistance through restoration of a caspase‐independent apoptotic pathway

Cancer science, 2009-08, Vol.100 (8), p.1460-1467

2009

Volltextzugriff (PDF)

Microtubule‐damaging agents enhance RASSF1A‐induced cell death in lung cancer cell lines

Cancer, 2009-03, Vol.115 (6), p.1253-1266

2009

Volltextzugriff (PDF)

Antitumor Activity of Poly(l-glutamic acid)-Paclitaxel on Syngeneic and Xenografted Tumors

Clinical cancer research, 1999-04, Vol.5 (4), p.891-897

1999

Volltextzugriff (PDF)

Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line

Cancer science, 1994-03, Vol.85 (3), p.290-297

1994

Volltextzugriff (PDF)

Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models

Clinical cancer research, 2004-11, Vol.10 (21), p.7382-7391

2004

Volltextzugriff (PDF)

Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents

Investigative ophthalmology & visual science, 2015-02, Vol.56 (2), p.1274-1282

2015

Volltextzugriff (PDF)

Water-soluble Taxol Conjugates with Dextran and Targets Tumor Cells by Folic Acid Immobilization

Anticancer research, 2010-03, Vol.30 (3), p.903-909

2010

Volltextzugriff (PDF)

Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis

Investigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.332-337

2018

Volltextzugriff (PDF)

Preclinical evaluation of antisense bcl‐2 as a chemosensitizer for patients with gastric carcinoma

Cancer, 2004-11, Vol.101 (10), p.2177-2186

2004

Volltextzugriff (PDF)

Vitamin B-6 deficiency is common and associated with poor long-term outcome in renal transplant recipients

The American journal of clinical nutrition, 2017-06, Vol.105 (6), p.1344-1350

2017

Volltextzugriff (PDF)

Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status

Cancer science, 2003-01, Vol.94 (1), p.125-133

2003

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Zeitschrift / SerieMnemosyne

KollektionEZB Electronic Journals Library

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(17)
Deutsch
(2)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(49)
Humans
(39)
Animals
(32)
Biological And Medical Sciences
(27)
Medical Sciences
(21)
Oncology
(19)
Female
(17)
Male
(15)
Mice
(14)
Science & Technology - Other Topics
(14)
Tumors
(13)
Multidisciplinary Sciences
(12)
Paclitaxel
(12)
Cell Line, Tumor
(11)
Chemotherapy
(11)
Antineoplastic Agents
(9)
Middle Aged
(9)
Pharmacology. Drug Treatments
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Therapeutic Tissue Crosslinking (TXL) for Myopia Using Second Harmonic Generation Signal Microscopy in Rabbit Sclera

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group

Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

Follow up of a multicenter phase II study of sequential paclitaxel and S-1 (TXL/S1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

A multicenter phase II study of sequential paclitaxel and S-1 (TXL/S-1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer

A bumblebee thioredoxin-like protein gene that is up-regulated by a temperature stimulus and lipopolysaccharide injection

Tongxinluo promotes mesenchymal stem cell tube formation in vitro

Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

Vacuolar H+‐ATPase inhibitors overcome Bcl‐xL‐mediated chemoresistance through restoration of a caspase‐independent apoptotic pathway

Microtubule‐damaging agents enhance RASSF1A‐induced cell death in lung cancer cell lines

Antitumor Activity of Poly(l-glutamic acid)-Paclitaxel on Syngeneic and Xenografted Tumors

Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line

Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models

Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents

Water-soluble Taxol Conjugates with Dextran and Targets Tumor Cells by Folic Acid Immobilization

Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis

Preclinical evaluation of antisense bcl‐2 as a chemosensitizer for patients with gastric carcinoma

Vitamin B-6 deficiency is common and associated with poor long-term outcome in renal transplant recipients

Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status

Aktive Filter

Suchergebnisse filtern